Allogeneic Stem Cell Therapies
Allogeneic Stem Cell Therapies involve the use of stem cells sourced from a genetically non-identical donor, typically a matched sibling or unrelated donor. These therapies are widely used in treating blood disorders, cancers like leukemia, and immune system diseases. Allogeneic stem cells offer the advantage of being readily available for patients in need, but they also present challenges such as immune rejection and graft-versus-host disease (GVHD). Despite these hurdles, ongoing advancements in immunosuppression, genetic modification, and tissue matching are enhancing the safety and effectiveness of allogeneic stem cell therapies.
Related Conference of Allogeneic Stem Cell Therapies
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Allogeneic Stem Cell Therapies Conference Speakers
Recommended Sessions
- Dental Stem Cells
- Adult Stem Cells
- AI in Stem Cell Research
- Allogeneic Stem Cell Therapies
- Autologous Stem Cells Therapies
- Biotech Innovations
- Cancer Stem Cells
- Clinical Trials
- CRISPR and Gene Editing
- Nanotechnology and Stem Cells
- Neural Stem Cells
- Organoids Technology
- Pluripotent Stem Cells
- Stem Cell Banking and Preservation
- Stem Cell Bioprocessing
- Stem Cell Gene Therapy
- Stem Cell Therapy
- Stem Cell-Based Immunotherapies
- Stem Cells in Oral Health
- Tissue Engineering
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)